Know About us
Stratos BioCapital is a global life sciences investment firm committed to advancing breakthrough innovations.
Our firm
Spun out from Stratos Capital, Stratos BioCapital was founded with a global vision – funding breakthrough innovations across geographies while leveraging deep industry expertise to drive biotech innovation and company growth.
To date, Stratos BioCapital has raised multiple investment funds backed by leading institutional and strategic investors, supporting a portfolio of cutting-edge biotech companies, both private and public.
Our team
Stratos BioCapital is led by a team of seasoned investment professionals, venture partners, and advisors spanning three continents. Our team brings diverse expertise across biotech, clinical development, regulatory affairs, commercial strategy, and business development.
With over a century of combined investment experience, our leadership has a proven track record in emerging and established biotech, diagnostics, and medtech, as well as global life sciences companies and key regulatory agencies such as the FDA and the European Medicines Agency (EMA).
Our strategy
At Stratos BioCapital, we specialize in building innovative and transformative healthcare and life sciences companies at the early and growth stages, across the globe.
Our forward-thinking investment strategy is designed to anticipate industry and policy trends, allowing us to adapt and maintain a competitive edge.
We invest across various life sciences sub-sectors, geographies, and development stages, leveraging our diverse cross-functional expertise to create value from company formation through to public market investments
Our investment model
Incubation
At Stratos BioCapital, we employ a Venture Operator model to create and scale companies, often tapping into our Venture Partners to lead these ventures. Our global incubation platform, paired with a network of experienced, homegrown CXOs, enables us to accelerate growth and operational success
Early stage
Our investment strategy is driven by a meticulous, iterative selection process designed to evaluate and mitigate risk across technology, people, and valuation.
We conduct thorough research and deep dives to uncover emerging science and innovative breakthroughs.
We actively lead or co-lead early-stage investments, securing board representation in the majority of our portfolio companies. Our extensive global network spans academia, industry, and investors, enabling us to leverage long-term relationships to strengthen and expand our portfolio.
Expansion stage
As active investors, we go beyond providing economic capital. Through our venture operator model, we take a hands-on approach to portfolio management, working closely with our companies to build lasting value and drive growth.
Public investing
With a keen eye for innovation and growth, we strategically target public market opportunities that offer substantial upside potential, applying our venture-driven approach to unlock value